TRIKAFTA
Identification of Trikafta
| No description |
Google image searchProduct monograph
Active ingredients
tezacaftor, 50 MG
ivacaftor, 75 MG
ivacaftor, 150 MG
elexacaftor, 100 MG
DIN: 02517140
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
Date: 22-JUN-2021
ATC:
- R07 — OTHER RESPIRATORY SYSTEM PRODUCTS (ATC, ATC/DDD, )
- R07A — OTHER RESPIRATORY SYSTEM PRODUCTS (ATC, ATC/DDD)
- R07AX — Other respiratory system products (ATC, ATC/DDD)
- R07AX32 — IVACAFTOR, TEZACAFTOR AND ELEXACAFTOR (ATC/DDD)
